Evidence map›Paper›PMID 39817556›Full record

Observational studyJournal of the American Heart Association2025

Prognostic Value of D-Dimer in Acute Type A Aortic Dissection and Intramural Hematoma: Observations from the Acute Aortic Syndrome Group of the Registry of Acute Non-Traumatic Chest Pain in China.

Lingyue Qiu, Qingwei Ji, Huangtai Miao, Meiying Long, Ming Gong, Jing Ye, Tianxiao Liu, Tianlong Zhang, Zhaohe Huang, Yan Liu and 12 more

Abstract readObservational StudyMulticenter Study
In one paragraph

Observational study in Journal of the American Heart Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Lingyue QiuGuangxi Chest Pain Center, and Department of Cardiology, The People's Hospital of Guangxi Zhuang Autonomous Region, and Institute of Cardiovascular Diseases, Guangxi Academy of Medical Sciences Nanning China.ORCID 0000-0002-1263-5420
Qingwei JiGuangxi Chest Pain Center, and Department of Cardiology, The People's Hospital of Guangxi Zhuang Autonomous Region, and Institute of Cardiovascular Diseases, Guangxi Academy of Medical Sciences Nanning China.ORCID 0000-0002-6355-433X
Huangtai MiaoChest Pain Center, and Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical Center for Coronary Heart Disease, and Beijing Institute of Heart Lung, and Blood Vessel Diseases Beijing China.
Meiying LongGuangxi Chest Pain Center, and Department of Cardiology, The People's Hospital of Guangxi Zhuang Autonomous Region, and Institute of Cardiovascular Diseases, Guangxi Academy of Medical Sciences Nanning China.
Ming GongDepartment of Cardiovascular Surgery, Beijing Anzhen Hospital, Capital Medical University, and The Key Laboratory of Cardiovascular Remodeling-related Diseases, Ministry of Education, and Beijing Institute of Heart Lung and Blood Vessel Disease Beijing China.ORCID 0009-0009-5665-6600
Jing YeChest Pain Center, and Department of Cardiology Renmin Hospital of Wuhan University Wuhan Hubei China.
Tianxiao LiuGuangdong Provincial Geriatrics Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences Guangzhou China.ORCID 0000-0001-5050-8804
Tianlong ZhangChest Pain Center, Beijing Chaoyang Integrative Medicine Rescue and First Aid Hospital Beijing China.
Zhaohe HuangChest Pain Center, and Department of Cardiology Affiliated Hospital of Youjiang Medical University for Nationalities Beijing China.
Yan LiuChest Pain Center, and Department of Cardiology Affiliated Hospital of Youjiang Medical University for Nationalities Beijing China.ORCID 0000-0002-9385-1159
Na YinChest Pain Center, and Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical Center for Coronary Heart Disease, and Beijing Institute of Heart Lung, and Blood Vessel Diseases Beijing China.
Xiaoyan WuChest Pain Center, and Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical Center for Coronary Heart Disease, and Beijing Institute of Heart Lung, and Blood Vessel Diseases Beijing China.
Ying ShiGuangxi Chest Pain Center, and Department of Cardiology, The People's Hospital of Guangxi Zhuang Autonomous Region, and Institute of Cardiovascular Diseases, Guangxi Academy of Medical Sciences Nanning China.
Huayuan ZengGuangxi Chest Pain Center, and Department of Cardiology, The People's Hospital of Guangxi Zhuang Autonomous Region, and Institute of Cardiovascular Diseases, Guangxi Academy of Medical Sciences Nanning China.
Ling LiuGuangxi Chest Pain Center, and Department of Cardiology, The People's Hospital of Guangxi Zhuang Autonomous Region, and Institute of Cardiovascular Diseases, Guangxi Academy of Medical Sciences Nanning China.
Yingzhong LinGuangxi Chest Pain Center, and Department of Cardiology, The People's Hospital of Guangxi Zhuang Autonomous Region, and Institute of Cardiovascular Diseases, Guangxi Academy of Medical Sciences Nanning China.
Liwen LyuGuangxi Chest Pain Center, and Department of Emergency the People's Hospital of Guangxi Zhuang Autonomous Region and Research Center of Cardiovascular Disease, Guangxi Academy of Medical Sciences Nanning China.
Wei ChenChest Pain Center, and Heart Center, Guilin People's Hospital Guilin China.
Hua SuChest Pain Center, and Department of Cardiology Hezhou People's Hospital Hezhou China.
Guoping ShiDepartment of Medicine Brigham and Women's Hospital and Harvard Medical School Boston MA USA.ORCID 0000-0001-5809-2567
Hai GaoChest Pain Center, and Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical Center for Coronary Heart Disease, and Beijing Institute of Heart Lung, and Blood Vessel Diseases Beijing China.ORCID 0000-0001-5426-6937
Hongjia ZhangDepartment of Cardiovascular Surgery, Beijing Anzhen Hospital, Capital Medical University, and The Key Laboratory of Cardiovascular Remodeling-related Diseases, Ministry of Education, and Beijing Institute of Heart Lung and Blood Vessel Disease Beijing China.ORCID 0000-0002-5737-4084

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAcute type A aortic dissection (AAD) and acute type A intramural hematoma (AIMH) are life-threatening conditions with high mortality rates, and prognostic indicators are critical for guiding urgent treatment decisions. We assessed the prognostic significance of admission D-dimer levels in patients with AAD and AIMH. METHODS AND

resultsThe prospective, multicenter, observational study in China recruited participants from 2013 to 2019. Patients with AAD and AIMH were respectively categorized into quartiles based on admission D-dimer levels. Cox regression analysis was used to assess the association between D-dimer levels and mortality. A total of 3132 patients with AAD (mean age: 50.63 years [SD, 12.56]) and 353 patients with AIMH (mean age: 59.63 years [SD, 11.00]) were included. In patients with AAD, overall mortality rates increased across D-dimer quartiles: 13.7% (Q1, ≤0.72 mg/L), 16.7% (Q2, 0.72-1.91 mg/L), 22.8% (Q3, 1.91-4.21 mg/L), and 28.5% (Q4, 4.21-20.00 mg/L). In patients with AIMH, mortality rates by quartile were 3.4% (Q1, ≤0.51 mg/L), 5.7% (Q2, 0.51-1.25 mg/L), 4.6% (Q3, 1.25-3.44 mg/L), and 10.2% (Q4, 3.44-20.00 mg/L). After adjusting for confounders, D-dimer was an independent predictor of overall mortality (hazard ratio [HR], 1.42 [95% CI, 1.11-1.80]) and in-hospital mortality (HR, 1.47 [95% CI, 1.13-1.92]) in patients with AAD. D-dimer levels were not significantly associated with the overall (HR, 2.61 [95% CI, 0.70-9.73]) or in-hospital mortality (HR, 1.78 [95% CI, 0.44-7.24]) of patients with AIMH by multivariable adjustment.

conclusionsElevated admission D-dimer levels are independently associated with higher mortality in patients with AAD but are not significantly associated with prognosis in patients with AIMH. Our findings suggest that D-dimer may serve as a useful prognostic marker in patients with AAD. REGISTRATION: www.chictr.org.cn. Unique identifier: ChiCTR230006854.

Indexed as

Aortic AneurysmAortic Aneurysm, ThoracicAortic DissectionChest PainFibrin Fibrinogen Degradation ProductsHematomaAcute Aortic SyndromeAcute DiseaseAdultAgedBiomarkersChinaFemaleHumansMaleMiddle AgedBiomarkersFibrin Fibrinogen Degradation Productsfibrin fragment Dacute type A aortic dissectionacute type A intramural hematomaD‐dimermortalityprognosis

Identifiers

PMID39817556
PMCPMC12054470

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.